---

Furunculosis of the Nasal Vestibule

A Comprehensive 50-Mark Answer with Diagrams, Flowcharts, and References

---

1. DEFINITION

Dhingra (Diseases of Ear, Nose & Throat): "A furuncle is an acute staphylococcal infection of a hair follicle. In the nose, it is confined to the vestibule, which is the only part of the nose bearing hair-bearing skin."

Hazarika (Textbook of ENT & Head and Neck Surgery): "Furunculosis of the nose is common because the nasal vestibule has vibrissae (coarse hairs) with associated sebaceous glands, and the skin here is tight and adherent to the underlying cartilage, making even small infections intensely painful."

---

2. SURGICAL ANATOMY OF THE NASAL VESTIBULE

┌─────────────────────────────────────────────────────────────┐
│            ANATOMY OF THE NASAL VESTIBULE                   │
│                                                             │
│  External Naris (Nostril)                                   │
│         │                                                   │
│         ▼                                                   │
│  ┌──────────────────────────┐                               │
│  │   NASAL VESTIBULE        │ ← Lined by SKIN (not mucosa)  │
│  │                          │                               │
│  │  • Vibrissae (hairs)     │ ← Pilosebaceous units        │
│  │  • Sebaceous glands      │ ← Source of infection        │
│  │  • Sweat glands          │                               │
│  │  • Skin tightly bound    │ ← Causes intense pain        │
│  │    to alar cartilage     │                               │
│  └──────────────────────────┘                               │
│         │                                                   │
│         ▼                                                   │
│  Limen Nasi (junction of vestibule and nasal cavity proper) │
│         │                                                   │
│         ▼                                                   │
│  Nasal Cavity Proper (lined by respiratory mucosa)          │
└─────────────────────────────────────────────────────────────┘

Boundaries of Nasal Vestibule:
  Anterior: External naris/nostril
  Posterior: Limen nasi (mucocutaneous junction)
  Medial: Columella (membranous septum)
  Lateral: Alar cartilage (lower lateral cartilage)
  Superior: Dome of lower lateral cartilage
  Floor: Junction of columella and floor of nose

• The nasal vestibule is the only hair-bearing area of the nasal cavity
• Skin here is stratified squamous epithelium continuous with the facial skin
• The skin is tightly adherent to the lower lateral (alar) cartilages — explaining the exquisite tenderness
• Vibrissae (nasal hairs) act as both a filtration barrier and as a potential nidus for infection when their follicles are traumatized
• Vascular connections: Angular vein → ophthalmic vein → cavernous sinus (the critical anatomical danger)

---

3. THE "DANGER TRIANGLE" OF THE FACE

         DANGER TRIANGLE OF THE FACE
         
              Nasion (root of nose)
                    /\
                   /  \
                  /    \
                 /      \
                /  NASAL  \
               /VESTIBULE  \
              /  (furuncle) \
             /________________\
       Left angle of         Right angle of
         mouth                  mouth
         
   ════════════════════════════════════════════
   VENOUS DRAINAGE PATHWAY (No valves!):
   
   Facial Vein → Angular Vein
        ↓
   Superior Ophthalmic Vein
        ↓
   Cavernous Sinus ← ← ← THROMBOSIS RISK!
   ════════════════════════════════════════════

---

4. ETIOLOGY & PREDISPOSING FACTORS

Causative Organisms

Harrison's Principles of Internal Medicine, 21st Ed. (p. 1541): "Furunculosis is caused by S. aureus, and this disorder has gained prominence in the past few decades because of CA-MRSA... Patients frequently believe they have been bitten by spiders or insects. Family members or close contacts may also be affected."

Predisposing Factors (Dhingra; Zakir Hussain's ENT)

1. Local trauma — nose picking (rhinotillexomania), plucking/trimming nasal hairs, ill-fitting nasogastric tubes, nasal cannulae for oxygen
2. Diabetes mellitus — impaired neutrophil function, poor glycemic control
3. Obesity — altered skin microbiome, increased sebaceous activity
4. Immunosuppression — HIV/AIDS, corticosteroid therapy, chemotherapy
5. Nasal carriage of S. aureus — ~30% of population are persistent nasal carriers; nasal vestibule is the primary reservoir
6. Atopic dermatitis / eczema — disrupted skin barrier, colonization
7. Chronic rhinorrhea — maceration of vestibular skin
8. Iron deficiency anemia — recurrent furunculosis
9. Hypogammaglobulinemia
10. Recurrent furunculosis suggests an underlying immunodeficiency (Job's syndrome/Hyper-IgE syndrome)

---

5. PATHOLOGY & PATHOGENESIS

PATHOGENESIS FLOWCHART
═══════════════════════════════════════════════════════════════
                        PREDISPOSING FACTOR
                   (trauma, nose picking, NG tube)
                              │
                              ▼
                   Breach in vestibular skin
                              │
                              ▼
               S. aureus enters pilosebaceous unit
                              │
                              ▼
              Hair follicle infection (FOLLICULITIS)
                              │
                              ▼
          Extension into perifollicular dermis
                              │
                              ▼
              Polymorphonuclear leukocyte recruitment
              ↓                                ↓
     Coagulase-positive               Fibrin wall formation
     S. aureus produces:              (localization attempt)
     • Coagulase → fibrin wall
     • Hyaluronidase → spreads
     • Leukocidin → destroys PMNs
     • Toxins → necrosis
                              │
                              ▼
              Central necrosis + liquefaction
                              │
                              ▼
              FURUNCLE (abscess of hair follicle)
                    with "pointing"
                              │
              ┌───────────────┴──────────────┐
              ▼                              ▼
      Spontaneous                    Inadequate or
      rupture and                    improper treatment
      healing                              │
                                           ▼
                               Retrograde venous spread
                               (angular vein → ophthalmic
                                vein → cavernous sinus)
                                           │
                                           ▼
                               CAVERNOUS SINUS THROMBOSIS
═══════════════════════════════════════════════════════════════

• Perifollicular abscess surrounded by intense neutrophilic infiltrate
• Central area of necrosis containing dead neutrophils ("pus"), fibrin, and bacterial colonies
• Fibrous capsule attempting to wall off infection
• Surrounding edema and dermal hyperemia
• In PVL-producing MRSA: extensive tissue necrosis due to cytolytic toxin

---

6. CLINICAL FEATURES

Symptoms

Signs

Hazarika (ENT & Head-Neck Surgery): "The patient presents with a red, swollen, acutely tender nasal tip. The pain is disproportionate to the size of the lesion. In severe cases, the entire tip and ala are red, swollen and exquisitely tender — do not confuse with relapsing polychondritis."

Scott-Brown's, 8th Ed.: "The skin overlying the abscess is tense, shiny and red, with a yellow-white point. Premature squeezing by the patient or incision before pointing is associated with the feared complication of cavernous sinus thrombosis."

---

7. STAGES OF FURUNCULOSIS

STAGES OF NASAL FURUNCULOSIS
══════════════════════════════════════════════════════════
STAGE 1 — FOLLICULITIS
  • Superficial infection confined to hair follicle opening
  • Tiny pustule at follicular orifice
  • Minimal pain
  • No induration

        ↓ (without treatment or with manipulation)

STAGE 2 — FURUNCLE (BOIL)
  • Deep infection of entire pilosebaceous unit
  • Erythematous, indurated nodule
  • Severe throbbing pain
  • Central necrosis begins
  • ± Low-grade fever

        ↓ (with progression)

STAGE 3 — ABSCESS FORMATION (POINTING)
  • Liquefaction of central necrotic core
  • Visible white/yellow "point" at center
  • Fluctuance palpable
  • Maximum swelling and tenderness
  • Fever

        ↓ (natural course)

STAGE 4 — RESOLUTION
  • Spontaneous rupture and drainage of pus
  • Relief of pain
  • Healing by granulation
══════════════════════════════════════════════════════════

---

8. DIAGNOSIS

Clinical Diagnosis

Investigations

---

9. DIFFERENTIAL DIAGNOSIS

---

10. COMPLICATIONS

FLOWCHART — COMPLICATIONS OF NASAL FURUNCULOSIS

                    NASAL FURUNCLE
                         │
         Premature/forceful squeezing
         OR inadequate treatment
                         │
                         ▼
              SEPTIC THROMBOPHLEBITIS
              of facial veins
                         │
              ┌──────────┴──────────────┐
              ▼                         ▼
    ORBITAL CELLULITIS           SEPTICEMIA
    • Proptosis                  • Bacteremia
    • Chemosis                   • Endocarditis
    • Ophthalmoplegia            • Metastatic abscesses
              │
              ▼
    CAVERNOUS SINUS THROMBOSIS (CST)
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    Symptoms:
    • High spiking fever, rigors
    • Headache (retro-orbital)
    • Proptosis (bilateral)
    • Chemosis (conjunctival edema)
    • Ophthalmoplegia (CN III, IV, VI palsy)
    • Periorbital edema
    • Pupillary changes
    • Meningism
    • Altered consciousness (CSF involvement)
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    Cranial nerve involvement:
    • CN III → Ptosis, mydriasis, down-out eye
    • CN IV → Trochlear palsy
    • CN V1/V2 → Periorbital/facial sensory loss
    • CN VI → Lateral rectus palsy (earliest sign)
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
              │
              ▼
    MENINGITIS / BRAIN ABSCESS
    • High mortality if untreated
    • Mortality ~30% with treatment
              │
              ▼
    CAROTID ARTERY INVOLVEMENT
    • Septic arteritis
    • Carotid blow-out (rare)

Harrison's, 21st Ed. (p. 12513): "Cavernous sinus thrombosis, often secondary to infection from orbital cellulitis (frequently Staphylococcus aureus), a cutaneous source on the face, or sinusitis, presents as orbital pain, proptosis, chemosis, fever, oculomotor neuropathy affecting CN III, IV, VI, and trigeminal neuropathy affecting V1 and occasionally V2."

Other Complications

---

11. TREATMENT

MANAGEMENT FLOWCHART

FURUNCULOSIS OF NASAL VESTIBULE — MANAGEMENT ALGORITHM
═══════════════════════════════════════════════════════════════════

PATIENT PRESENTS WITH NASAL TIP PAIN/SWELLING
                    │
                    ▼
           CLINICAL ASSESSMENT
    (History, examination, anterior rhinoscopy)
                    │
           ┌────────┴────────────────┐
           ▼                         ▼
   EARLY STAGE                 ESTABLISHED FURUNCLE
   (Folliculitis/           (Induration, ± pointing)
   pre-abscess)                       │
           │                 ┌────────┴─────────────┐
           ▼                 ▼                       ▼
   Conservative          NOT YET               POINTING/
   treatment             POINTING              FLUCTUANT
                         │                       │
                         ▼                       ▼
                   Conservative              INCISION &
                   treatment +              DRAINAGE (I&D)
                   systemic antibiotics
                    
═══════════════════════════════════════════════════════════════════

CONSERVATIVE TREATMENT:
  1. Warm fomentations (hot saline soaks)
  2. Topical mupirocin 2% ointment TDS × 5–7 days
  3. Systemic antibiotics (see below)
  4. STRICT advice: DO NOT SQUEEZE
  5. Analgesics (NSAIDs/paracetamol)
  6. Glycemic control in diabetics

ANTIBIOTICS — EMPIRICAL THERAPY:

  ┌──────────────────────────────────────────────────────────┐
  │ MSSA (Community, no MRSA risk factors)                   │
  │  → Cloxacillin 500mg QID × 7 days (oral)                │
  │  → OR Flucloxacillin 500mg QID × 7 days                 │
  │  → OR Amoxicillin-Clavulanate 625mg TDS × 7 days        │
  │  → OR Cefalexin 500mg QID × 7 days                      │
  └──────────────────────────────────────────────────────────┘
  
  ┌──────────────────────────────────────────────────────────┐
  │ CA-MRSA (No systemic involvement)                        │
  │  → TMP-SMX (Trimethoprim-Sulfamethoxazole) DS BD × 7d  │
  │  → OR Clindamycin 300mg TDS × 7 days                    │
  │  → OR Doxycycline 100mg BD × 7 days                     │
  │  → OR Linezolid 600mg BD × 10 days (reserve)            │
  └──────────────────────────────────────────────────────────┘
  
  ┌──────────────────────────────────────────────────────────┐
  │ SEVERE / COMPLICATED / SEPTICEMIA / CST                  │
  │  → IV Vancomycin 15–20 mg/kg BD (guided by trough)      │
  │  → OR IV Daptomycin 4–6 mg/kg OD                        │
  │  → OR IV Linezolid 600mg BD                             │
  │  → ANTICOAGULATION for CST (heparin — controversial)    │
  └──────────────────────────────────────────────────────────┘

═══════════════════════════════════════════════════════════════════

Harrison's, 21st Ed. (p. 4449): "The increase in SSTIs caused by CA-MRSA has drawn attention to the need for initiation of appropriate empirical therapy. Even small abscesses appear to benefit from antibiotic therapy in addition to incision and drainage. Antibiotics include clindamycin, trimethoprim-sulfamethoxazole, doxycycline, linezolid, and tedizolid. Parenteral therapy is reserved for more complicated infections."

Harrison's, 21st Ed. (p. 1541): "Warm compresses and nasal mupirocin are helpful therapeutic additions. Severe infections may require IV antibiotics."

Incision and Drainage (I&D)

• Fluctuant, pointing abscess
• Failure to respond to 48–72 hours of conservative therapy
• Large abscess with significant swelling

1. Apply topical anaesthetic (lignocaine + adrenaline cream) to vestibule for 10 minutes
2. Infiltration with 1% lignocaine + 1:200,000 adrenaline
3. Stab incision at the point of maximum fluctuance using a No. 11 scalpel blade, directed away from the septum
4. Blunt dissection with mosquito forceps to break loculations
5. Thorough irrigation with normal saline
6. Light wick/Vaseline gauze drain for 24–48 hours
7. Send pus for culture and sensitivity

CRITICAL WARNING (Scott-Brown's; Cummings): Never incise prematurely (before pointing/fluctuance) and never squeeze — this forces infected material into the valveless venous system, triggering retrograde thrombophlebitis and potentially fatal cavernous sinus thrombosis.

Treatment of Cavernous Sinus Thrombosis

MANAGEMENT OF CST (secondary to nasal furunculosis)
════════════════════════════════════════════════════
1. URGENT HOSPITALIZATION (ICU/HDU if indicated)
2. IV antibiotics — anti-MRSA regimen
   → Vancomycin + Metronidazole + 3rd gen cephalosporin
3. ANTICOAGULATION (controversial but widely practiced)
   → Therapeutic LMWH or unfractionated heparin
   → Role: prevents propagation of thrombus
4. Corticosteroids — considered to reduce inflammation
   (high-dose dexamethasone, short course)
5. OPHTHALMOLOGY consultation for eye involvement
6. NEUROSURGERY if intracranial abscess
7. Supportive: IV fluids, antipyretics, analgesia
8. Monitor: blood culture, repeat MRI, ophthalmology
════════════════════════════════════════════════════

---

12. MANAGEMENT OF RECURRENT FURUNCULOSIS

RECURRENT FURUNCULOSIS — INVESTIGATION & MANAGEMENT
═════════════════════════════════════════════════════════

STEP 1: INVESTIGATE UNDERLYING CAUSE
  • Blood glucose / HbA1c → Diabetes
  • CBC + differential → Neutropenia, eosinophilia
  • Serum IgG, IgA, IgM → Hypogammaglobulinemia
  • Serum IgE + eosinophil → Hyper-IgE (Job's syndrome)
  • HIV test
  • Iron studies, ferritin → Iron deficiency
  • Nasal swabs (family/contacts) → MRSA carriage screening

STEP 2: ERADICATION OF NASAL MRSA CARRIAGE
  Protocol (DECOLONIZATION):
  • Mupirocin 2% nasal ointment TDS × 5 days
    applied to both anterior nares
  • Chlorhexidine body wash daily × 5 days
  • Change pillowcases, towels, clothes
  • Screen and treat household contacts simultaneously
  • Repeat swabs at 2 and 4 weeks

STEP 3: SYSTEMIC THERAPY
  • Oral clindamycin / TMP-SMX for active lesions
  • Long-term low-dose tetracycline considered
  • Rifampicin 300mg BD × 10 days (MRSA decolonization)
    — must be combined with another agent (resistance)

STEP 4: CORRECT UNDERLYING CAUSES
  • Optimize diabetes control
  • IVIG for immunoglobulin deficiency
  • Iron supplementation
  • Address behavioral habits (nose picking)
═════════════════════════════════════════════════════════

---

13. RECENT ADVANCES

1. CA-MRSA and PVL-Producing Strains (Post-2000)

• Produce a cytolytic toxin that destroys neutrophil membranes
• Cause deeper, more necrotic, recurrent infections
• Account for >75% of CA-MRSA SSTIs in some regions
• USA300 and USA400 are predominant CA-MRSA clones in North America
• Empirical therapy must now cover CA-MRSA even in community settings

2. Decolonization Protocols

3. Novel Topical Agents

4. Point-of-Care MRSA PCR Testing

5. Role of Biofilm in Recurrent Furunculosis

6. Phage Therapy (Experimental)

7. Anticoagulation in CST

8. Immunotherapy for Recurrent S. aureus Infections

---

14. PROGNOSIS

---

15. SUMMARY TABLE — FURUNCULOSIS OF NASAL VESTIBULE

---

REFERENCES

1. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery, 8th Ed. — Chapter on External Nose and Nasal Vestibule
2. Cummings Otolaryngology – Head and Neck Surgery, 7th Ed. — Chapter on Diseases of the External Nose
3. Stell & Maran's Head & Neck Surgery and Oncology, 5th Ed. — Infections of the External Nose
4. Zakir Hussain's Textbook of ENT & Head-Neck Surgery — Diseases of the Nasal Vestibule
5. Dhingra PL, Diseases of Ear, Nose & Throat, 7th Ed. — Ch. 30: Diseases of External Nose
6. Hazarika P, Textbook of ENT & Head and Neck Surgery, 3rd Ed. — Furunculosis of Nose
7. Harrison's Principles of Internal Medicine, 21st Ed., pp. 1541, 4449, 12513 — Furunculosis, CA-MRSA SSTIs, Cavernous Sinus Thrombosis
8. Tong SYC et al. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 28(3):603–661.
9. Daum RS (2007). Skin and Soft-Tissue Infections Caused by MRSA. NEJM. 357:380–390.
10. Miller LG et al. (2015). Clinical and epidemiologic characteristics cannot distinguish PVL-positive S. aureus SSTIs from PVL-negative infections. Clin Infect Dis.
11. Huang SS et al. (REDUCE MRSA Trial) (2013). Targeted vs. Universal Decolonization to Prevent ICU Infection. NEJM. 368:2255–2265.

---

Examiner's Note: This question carries 50 marks — covering anatomy, etiology, pathogenesis, clinical features, differential diagnosis, complications (especially CST), medical and surgical management, recurrent furunculosis, and recent advances is essential. The "danger triangle", the role of valveless venous drainage, and the absolute contraindication to squeezing are high-yield clinical points that examiners specifically target.